GlassScriptPhysician profile
Mattison Gorrell
NPI 1629470265
$3,133.36
in general payments reported to CMS, 2019-2025
14 companies · $1,027 in 2025
The $1,027 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $56.40 · 2022: $176 · 2023: $604 · 2024: $1,270 · 2025: $1,027.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,901.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $631.47 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $512.08 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $354.97 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $295.78 | 2022-2025 | Zepbound, Jardiance, Mounjaro |
| Amgen INC. | $269.01 | 2023-2025 | Evenity, Prolia, Repatha |
| Pfizer INC. | $266.38 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $242.37 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $132.38 | 2023-2025 | Gemtesa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $126.37 | 2024-2025 | Ofev, Jardiance, Stiolto Respimat |
| Astellas Pharma US INC | $92.80 | 2023-2025 | Veozah |
| Exact Sciences Corporation | $76.42 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Axsome Therapeutics, INC. | $64.21 | 2025 | Auvelity |
| Phathom Pharmaceuticals, INC. | $52.12 | 2024-2025 | Voquezna |
| Seqirus USA INC | $17.00 | 2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mattison Gorrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.